Results
1859
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
1859 companies
Newbury Pharmaceuticals
Market Cap: SEK 70.9m
Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.
NEWBRY
SEK 2.67
7D
2.7%
1Y
-14.4%
Exelixis
Market Cap: US$11.7b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$42.39
7D
-6.6%
1Y
106.1%
Nanoform Finland Oyj
Market Cap: €83.8m
Engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States.
NANOFH
€0.98
7D
4.3%
1Y
-52.5%
Sopharma AD
Market Cap: лв1.1b
Produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally.
SFA
лв6.54
7D
0.6%
1Y
6.5%
ImmunoPrecise Antibodies
Market Cap: US$22.4m
Operates as a techbio company.
IPA
US$0.56
7D
12.6%
1Y
-49.8%
MacroGenics
Market Cap: US$99.7m
A clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States.
MGNX
US$1.51
7D
-4.4%
1Y
-66.8%
Intellia Therapeutics
Market Cap: US$979.9m
A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.
NTLA
US$9.16
7D
7.8%
1Y
-63.1%
Vicore Pharma Holding
Market Cap: SEK 1.9b
A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.
VICO
SEK 8.15
7D
-4.6%
1Y
-54.0%
Monopar Therapeutics
Market Cap: US$216.6m
A clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.
MNPR
US$35.45
7D
-4.6%
1Y
1,027.4%
Physiomics
Market Cap: UK£1.3m
Provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland.
PYC
UK£0.0042
7D
0%
1Y
-67.7%
LENZ Therapeutics
Market Cap: US$794.3m
Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.
LENZ
US$28.18
7D
5.1%
1Y
79.5%
Vaxcyte
Market Cap: US$4.4b
A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.
PCVX
US$32.54
7D
2.2%
1Y
-52.7%
Barinthus Biotherapeutics
Market Cap: US$32.7m
A clinical-stage biopharmaceutical company, focuses on developing immunotherapeutic drug candidates for treating auto-immune and inflammatory diseases.
BRNS
US$0.65
7D
-30.7%
1Y
-70.4%
Inhalation Sciences Sweden
Market Cap: SEK 65.8m
Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research.
ISAB
SEK 4.34
7D
0%
1Y
24.4%
Bayer (Peru)
Market Cap: S/294.5m
Engages in the pharmaceuticals, consumer health, and crop science businesses in Peru.
BAYERI1
S/20.00
7D
0%
1Y
41.8%
HBL - Hadasit Bio-Holdings
Market Cap: ₪4.5m
Operates in the biotechnology industry in Israel.
HDST-M
₪0.41
7D
0%
1Y
0%
Pharma-Bio Serv
Market Cap: US$9.9m
Operates as a regulatory affairs, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.
PBSV
US$0.43
7D
0%
1Y
-35.8%
Psyence Group
Market Cap: CA$1.4m
A life science biotechnology company, engages in the cultivation and production of commercial psilocybin mushroom.
PSYG
CA$0.15
7D
0%
1Y
-50.0%
G.F.C Green Fields Capital
Market Cap: ₪120.5m
Does not have significant operations.
GFC-M
₪12.00
7D
0.9%
1Y
n/a
JBM (Healthcare)
Market Cap: HK$2.1b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.60
7D
22.6%
1Y
170.8%
Hanmi Pharm
Market Cap: ₩3.7t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩292,000.00
7D
-0.3%
1Y
-2.0%
Beta Drugs
Market Cap: ₹17.4b
Develops, manufactures, and sells anti-cancer drugs in India.
BETA
₹1,720.75
7D
-3.7%
1Y
49.4%
Immutep
Market Cap: AU$430.8m
A late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases in Australia.
IMM
AU$0.29
7D
-3.3%
1Y
-33.7%
Zhejiang Jiuzhou Pharmaceutical
Market Cap: CN¥13.1b
Operates as contract development and manufacturing organization company in China and internationally.
603456
CN¥14.69
7D
3.2%
1Y
-3.5%
Jiangsu Sihuan Bioengineering
Market Cap: CN¥2.1b
Engages in the pharmaceutical business in China.
000518
CN¥2.08
7D
2.5%
1Y
-10.0%
BDH Industries
Market Cap: ₹1.5b
Engages in the manufacture and sale of therapeutic formulations covering a range of pharmaceuticals in India.
524828
₹262.60
7D
-3.1%
1Y
-27.9%
Binh Dinh Pharmaceutical and Medical Equipment
Market Cap: ₫4.8t
Manufactures and trades in pharmaceuticals and medical equipment in Vietnam.
DBD
₫51,500.00
7D
2.2%
1Y
22.6%
Quality Chemical Industries
Market Cap: USh317.7b
A pharmaceutical manufacturing company based in Uganda, produces treatments for HIV/AIDS, malaria, hepatitis, and other medical conditions.
QCIL
USh89.00
7D
2.3%
1Y
61.8%
China Traditional Chinese Medicine Holdings
Market Cap: HK$10.9b
China Traditional Chinese Medicine Holdings Co.
570
HK$2.17
7D
1.9%
1Y
-48.7%
CellSource
Market Cap: JP¥12.5b
Engages in the regenerative medicine-related businesses in Japan.
4880
JP¥629.00
7D
-3.4%
1Y
-52.7%
Guanhao BiotechLtd
Market Cap: CN¥3.6b
Develops, manufactures, and sells regenerative medicines and life sciences products primarily in China.
300238
CN¥13.50
7D
0.6%
1Y
30.7%
TMS
Market Cap: JP¥6.3b
Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.
4891
JP¥155.00
7D
6.9%
1Y
-32.0%
TaiwanJ Pharmaceuticals
Market Cap: NT$634.6m
A specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan.
6549
NT$7.92
7D
-0.9%
1Y
-32.9%
Oneness Biotech
Market Cap: NT$28.6b
Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products primarily in Taiwan.
4743
NT$59.90
7D
-3.9%
1Y
-58.9%
High Tech Pharm
Market Cap: ₩133.9b
Researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide.
A106190
₩12,590.00
7D
8.0%
1Y
-21.8%
Sinil Pharmaceutical
Market Cap: ₩75.9b
Manufactures and sells pharmaceutical products in South Korea and internationally.
A012790
₩6,670.00
7D
4.4%
1Y
-5.4%